Page last updated: 2024-09-04

sodium salicylate and Idiopathic Parkinson Disease

sodium salicylate has been researched along with Idiopathic Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nehru, B; Thakur, P1
Blandini, F; Desideri, S; Godi, L; Mancini, F; Martignoni, E; Nappi, G; Pacchetti, C1

Trials

1 trial(s) available for sodium salicylate and Idiopathic Parkinson Disease

ArticleYear
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA.
    Free radical biology & medicine, 1999, Volume: 27, Issue:3-4

    Topics: Antiparkinson Agents; Biomarkers; Blood Platelets; Dopamine; Female; Gentisates; Humans; Hydroxybenzoates; Hydroxyl Radical; In Vitro Techniques; Levodopa; Linear Models; Male; Middle Aged; Oxidative Stress; Parkinson Disease; Sodium Salicylate; Superoxide Dismutase; Tyrosine

1999

Other Studies

1 other study(ies) available for sodium salicylate and Idiopathic Parkinson Disease

ArticleYear
Modulatory effects of sodium salicylate on the factors affecting protein aggregation during rotenone induced Parkinson's disease pathology.
    Neurochemistry international, 2014, Volume: 75

    Topics: alpha-Synuclein; Animals; Body Weight; Glutathione; HSP70 Heat-Shock Proteins; Male; Nerve Tissue Proteins; Oxidation-Reduction; Parkinson Disease; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Rotenone; Sodium Salicylate; Ubiquitin

2014